Introduction Semaglutide has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://breastlifttreatment96418.wikilentillas.com/1103548/semaglutide_a_breakthrough_medication_for_weight_loss_diabetes_and_heart_health